Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo Pharma's shares fell by 2.22% to Rs 1,114.50 in early trading. Despite consistent financial growth, the stock is currently trading lower than its previous close.

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

The deal is being carried out on a cash-free, debt-free basis, factoring in standardised working capital levels.

Indian benchmark indices, BSE Sensex and NSE Nifty, are poised for a weak opening on Thursday after U.S. President Donald ...

Indian equity markets closed higher on Wednesday, led by gains in FMCG, IT, and consumer durables stocks. However, the ...

Stocks to Watch Today, Thursday, July 31, 2025: Indian equity markets are expected to start on a lower note on Thursday ...

Stocks including Tata Steel, Brigade Hotel Ventures, Mahindra & Mahindra, Jio Financial Services, IndiGo, LTIMindTree, ...

Tata Motors Ltd., Jio Financial Services Ltd. and JSW Steel Ltd. are some of the stocks that are going to be in the limelight ...